I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 29 studies | 29% ± 14% | |
| natural killer cell | 16 studies | 18% ± 3% | |
| memory B cell | 15 studies | 22% ± 5% | |
| naive B cell | 13 studies | 21% ± 8% | |
| microglial cell | 7 studies | 40% ± 14% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 20% ± 3% | |
| precursor B cell | 6 studies | 37% ± 10% | |
| macrophage | 6 studies | 28% ± 6% | |
| plasma cell | 5 studies | 29% ± 11% | |
| brush cell | 5 studies | 84% ± 13% | |
| non-classical monocyte | 4 studies | 26% ± 9% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 22% ± 2% | |
| plasmablast | 4 studies | 47% ± 13% | |
| germinal center B cell | 4 studies | 57% ± 15% | |
| gamma-delta T cell | 4 studies | 24% ± 7% | |
| dendritic cell | 4 studies | 27% ± 10% | |
| immature B cell | 3 studies | 33% ± 11% | |
| pro-B cell | 3 studies | 22% ± 2% | |
| lymphocyte | 3 studies | 19% ± 4% | |
| T follicular helper cell | 3 studies | 17% ± 3% | |
| glutamatergic neuron | 3 studies | 36% ± 9% | |
| ciliated cell | 3 studies | 21% ± 2% |
